Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Cash from Financing Activities (2016 - 2025)

Guided Therapeutics' Cash from Financing Activities history spans 15 years, with the latest figure at $267000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 49.24% to $267000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $745000.0, a 18.67% decrease, with the full-year FY2025 number at $745000.0, down 18.67% from a year prior.
  • Cash from Financing Activities hit $267000.0 in Q4 2025 for Guided Therapeutics, up from $181000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for GTHP hit a ceiling of $2.9 million in Q3 2022 and a floor of -$154000.0 in Q3 2023.
  • Historically, Cash from Financing Activities has averaged $346600.0 across 5 years, with a median of $188500.0 in 2023.
  • Biggest five-year swings in Cash from Financing Activities: surged 687.88% in 2022 and later plummeted 300.0% in 2024.
  • Tracing GTHP's Cash from Financing Activities over 5 years: stood at -$53000.0 in 2021, then increased by 20.75% to -$42000.0 in 2022, then skyrocketed by 566.67% to $196000.0 in 2023, then soared by 168.37% to $526000.0 in 2024, then crashed by 49.24% to $267000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for GTHP at $267000.0 in Q4 2025, $181000.0 in Q3 2025, and $239000.0 in Q2 2025.